248 related articles for article (PubMed ID: 18401539)
1. Intrathecal chemotherapy delivered by a lumbar-thecal catheter in metastatic medulloblastoma: a case illustration.
Clayton J; Vloeberghs M; Jaspan T; Walker D; MacArthur D; Grundy R
Acta Neurochir (Wien); 2008 Jul; 150(7):709-12. PubMed ID: 18401539
[TBL] [Abstract][Full Text] [Related]
2. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
Tran HC; Gardner S; Weiner HL; Liebes LF; Finlay JL
J Oncol Pharm Pract; 2014 Jun; 20(3):229-32. PubMed ID: 23929729
[TBL] [Abstract][Full Text] [Related]
3. Three-year recurrence-free survival in a patient with recurrent medulloblastoma after resection, high-dose chemotherapy, and intrathecal Yttrium-90-labeled DOTA0-D-Phe1-Tyr3-octreotide radiopeptide brachytherapy.
Beutler D; Avoledo P; Reubi JC; Mäcke HR; Müller-Brand J; Merlo A; Kühne T
Cancer; 2005 Feb; 103(4):869-73. PubMed ID: 15641034
[TBL] [Abstract][Full Text] [Related]
4. A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma.
Zamboni WC; Gajjar AJ; Mandrell TD; Einhaus SL; Danks MK; Rogers WP; Heideman RL; Houghton PJ; Stewart CF
Clin Cancer Res; 1998 Oct; 4(10):2537-44. PubMed ID: 9796988
[TBL] [Abstract][Full Text] [Related]
5. Clinical management of medulloblastoma in adults.
Eisenstat DD
Expert Rev Anticancer Ther; 2004 Oct; 4(5):795-802. PubMed ID: 15485314
[TBL] [Abstract][Full Text] [Related]
6. [Childhood medulloblastoma].
Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
[TBL] [Abstract][Full Text] [Related]
7. [Medulloblastoma with extracentral nervous system metastases: clinical presentation and risk factors].
Kochbati L; Bouaouina N; Hentati D; Nasr C; Besbes M; Benna F; Boussen H; Maalej M
Cancer Radiother; 2006 May; 10(3):107-11. PubMed ID: 16600659
[TBL] [Abstract][Full Text] [Related]
8. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
[TBL] [Abstract][Full Text] [Related]
9. Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor.
Stewart CF; Iacono LC; Chintagumpala M; Kellie SJ; Ashley D; Zamboni WC; Kirstein MN; Fouladi M; Seele LG; Wallace D; Houghton PJ; Gajjar A
J Clin Oncol; 2004 Aug; 22(16):3357-65. PubMed ID: 15310781
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma.
Edwards MS; Levin VA; Seager ML; Wilson CB
Childs Brain; 1981; 8(6):444-51. PubMed ID: 6796342
[TBL] [Abstract][Full Text] [Related]
11. Proposed strategy for the use of high-dose chemotherapy with stem cell rescue and intrathecal topotecan without whole-brain irradiation for infantile classic medulloblastoma.
Yamada A; Moritake H; Kamimura S; Yamashita S; Takeshima H; Nunoi H
Pediatr Blood Cancer; 2014 Dec; 61(12):2316-8. PubMed ID: 25174961
[TBL] [Abstract][Full Text] [Related]
12. [Local chemotherapy of cancer. Intrathecal administration].
Nagai M
Gan To Kagaku Ryoho; 1989 Feb; 16(2):156-64. PubMed ID: 2465738
[TBL] [Abstract][Full Text] [Related]
13. [Meningoradiculitis revealing an occult medulloblastoma-PNET in an adult].
Alla P; de Jauréguiberry JP; Carloz E; Gisserot O; Valance J; Jaubert D
Rev Neurol (Paris); 1998 Jul; 154(6-7):542-5. PubMed ID: 9773089
[TBL] [Abstract][Full Text] [Related]
14. [Medulloblastoma with mandibular metastasis after complete remission of the central nervous system lesions].
Yoshimura J; Nishiyama K; Takahashi H; Mori H; Tanaka R; Umezu H
No To Shinkei; 2005 Jan; 57(1):37-40. PubMed ID: 15782598
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma arising from an immature teratoma of the posterior fossa. Case report.
Das S; Muro K; Goldman S; Rajaram V; DiPatri AJ
J Neurosurg; 2007 Jan; 106(1 Suppl):61-4. PubMed ID: 17233316
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal chemotherapy with antineoplastic agents in children.
Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R
Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696
[TBL] [Abstract][Full Text] [Related]
17. Congenital medulloblastoma with atypical MRI appearance.
Komatsu F; Tsugu H; Nonaka M; Tsutsumi M; Yanai F; Yukitake K; Utsunomiya H; Fukushima T
Pediatr Neurosurg; 2008; 44(2):165-8. PubMed ID: 18230934
[TBL] [Abstract][Full Text] [Related]
18. Reversible occlusion shunt for intraventricular chemotherapy in shunt-dependent brain tumor patients.
Czech T; Reinprecht A; Dietrich W; Hainfellner JA; Slavc I
Pediatr Hematol Oncol; 1997; 14(4):375-80. PubMed ID: 9211542
[TBL] [Abstract][Full Text] [Related]
19. Supratentorial leptomeningeal metastasis of a medulloblastoma without cerebellar tumor recurrence.
Gerlach R; Kieslich M; van de Nes J; Galow W; Seifert V
Acta Neurochir (Wien); 2002 Feb; 144(2):201-4; discussion 204. PubMed ID: 11862522
[TBL] [Abstract][Full Text] [Related]
20. Metastatic medulloblastoma in 10-year-old girl treated successfully with chemotherapy without radiotherapy.
Schiavetti A; Varrasso G; Maurizi P; Trasimeni G; Carapella C; Castello MA
J Neurooncol; 1999; 45(1):55-60. PubMed ID: 10728910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
